← Back to Search

Cobalt + for Depression

University of Pennsylvania, Philadelphia, PA
Targeting 3 different conditionsCobalt +N/AWaitlist AvailableResearch Sponsored by University of Pennsylvania

Study Summary

This trial will test digital mental health interventions for healthcare workers to see if they are effective in addressing the mental health needs brought on by the pandemic.

Eligible Conditions
  • Depression
  • Well-being
  • Anxiety


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Depressive symptoms
Secondary outcome measures
Perceived System usability
Psychological well-being
Satisfaction with care
+2 more
Other outcome measures
DSM-5 Level 1 Cross-Cutting Symptom Measure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants will complete baseline surveys at enrollment and then complete subsequent surveys (depression, anxiety, well-being, satisfaction with access to care, work productivity) at enrollment; 0 months and then again at 6 months and 9 months. The intervention group receives usual Cobalt plus: 1) monthly automated text messaging reminders and links to Cobalt resources 2) intermittent mental health assessments which triage individuals to an appointment based on their results.
Group II: Usual CareActive Control1 Intervention
Participants will complete baseline surveys at enrollment and then complete subsequent surveys (depression, anxiety, well-being, satisfaction with access to care, work productivity, hours of direct patient care, percent of time providing care for patients with COVID-19) at enrollment; 0 months, 6 months, and 9 months.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
1,962 Previous Clinical Trials
42,525,262 Total Patients Enrolled
67 Trials studying Depression
28,184 Patients Enrolled for Depression

Media Library

Cobalt Clinical Trial Eligibility Overview. Trial Name: NCT05028075 — N/A
Depression Research Study Groups: Usual Care, Intervention
Depression Clinical Trial 2023: Cobalt Highlights & Side Effects. Trial Name: NCT05028075 — N/A
Cobalt 2023 Treatment Timeline for Medical Study. Trial Name: NCT05028075 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What primary goals are the researchers hoping to achieve with this medical experiment?

"Over the course of nine months, this clinical trial will track a primary outcome - depressive symptoms. Furthermore, secondary outcomes such as work productivity (measured with Lam Employment Absence and Productivity Scale or LEAPS), satisfaction with care (indexed utilizing Satisfaction Index- Mental Health or SIMH) and well-being (tracked using The Well-Being index or WBI) are also taken into consideration."

Answered by AI

How many participants have enlisted in this experiment?

"Affirmative. According to clinicaltrials.gov, this ongoing medical trial was first announced on November 29th 2021 and has most recently been updated on September 26th 2022. 1250 participants are being sought for the study at a single site."

Answered by AI

Is enrollment currently open for this research project?

"Data compiled on clinicaltrials.gov confirms that this medical trial is currently enrolling candidates. It was initially posted on the November 29th 2021 and has had its details revised most recently on September 26th 2022."

Answered by AI
~425 spots leftby Nov 2024